SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 35.99 |
| Enterprise Value ($M) | 39.16 |
| Book Value ($M) | -4.12 |
| Book Value / Share | -0.52 |
| Price / Book | -8.72 |
| NCAV ($M) | -16.00 |
| NCAV / Share | -2.00 |
| Price / NCAV | -2.25 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.92 |
| Return on Assets (ROA) | -0.69 |
| Return on Equity (ROE) | -2.69 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.82 |
| Current Ratio | 0.83 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 19.70 |
| Assets | 31.57 |
| Liabilities | 35.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | |||
| 13G/A | AWM Investment Company, Inc. | |||
| 13G/A | Mosca Alison | |||
| 13G/A | Citadel Advisors Llc | 4.50 | ||
| 13G/A | Vivo Opportunity Fund Holdings, L.P. | 7.00 | -29.53 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 15,518 | 50,557 | 30.69 | |
| 2,160 | 58,252 | 3.71 | |
| 9,483 | 47,011 | 20.17 | |
| 9,563 | 40,803 | 23.44 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CING – Cingulate Inc. | CKPT – Checkpoint Therapeutics, Inc. |
| CLDX – Celldex Therapeutics, Inc. | CLRB – Cellectar Biosciences, Inc. |
| CMPX – Compass Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io